Replimune Group, Inc.
Key Metrics
Market Snapshot
About
Replimune Group is a clinical-stage biotechnology company developing oncolytic immunotherapies for cancer treatment. The company focuses on engineered oncolytic viruses that selectively replicate in tumors to kill cancer cells while stimulating anti-tumor immune responses. Its lead candidate targets multiple solid tumor types.